High Volume Lactated Ringer's Solution and Pancreatitis
Perioperative Intravenous Administration of High Volume Lactated Ringer's Solution and the Risk of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Sponsor: Allina Health System
Terminated
Study was closed prematurely due to low enrollment numbers.
Other terminated trials from Allina Health System
Other Pancreatitis trials with similar outcome
A PHASE2/PHASE3 clinical study on Pancreatitis, this trial is terminated or withdrawn. The trial is conducted by Allina Health System and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Terminated PHASE2/PHASE3
-
Nov 2024 — Mar 2025 [monthly]
Terminated PHASE2/PHASE3
-
Sep 2024 — Nov 2024 [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2_PHASE3
-
Oct 2019 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
Jul 2019 — Oct 2019 [monthly]
Terminated PHASE2_PHASE3
-
Apr 2019 — Jul 2019 [monthly]
Terminated PHASE2_PHASE3
-
Jun 2018 — Apr 2019 [monthly]
Terminated PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Allina Health System
- Endeavor Health
- Medical College of Wisconsin
- University of Utah
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .